CivicaScript, a nonprofit generic drug company, has launched insulin glargine-yfgn and ustekinumab-aauz, expanding its national portfolio of low-cost treatments. The insulin product, which is ...

Mr. Scorsese is an Academy Award-winning director, writer and producer. Rob Reiner was my friend, and so was Michele. From now on, I’ll have to use the past tense, and that fills me with such profound ...

Brian Burns took a moment to consider the question. What has it been like to thrive individually this season, as the Giants fail? “What has it been like?” he told NJ Advance Media. “Like every other ...

Emma Kleck has been totally dependent on insulin, the lifesaving medication for people living with diabetes, for 25 years. Kleck, 32, of Santa Cruz, was diagnosed with the rarer Type 1 diabetes at age ...

David Grier “D.G.” Martin Jr., a former University of North Carolina system vice president, congressional candidate, lawyer and the host of UNC-TV’s North Carolina Bookwatch for two decades, died ...

Ed Burns believes his "two-week rule" with Christy Turlington is the secret behind their lasting marriage. The actor and filmmaker has been busy bringing "The Family McMullen" — the sequel to his 1995 ...

The light gray paint is now a yellow-green and two new wooden railings flank the front steps, but Edward Burns’ childhood home on Marlboro Road in Valley Stream otherwise looks much the same as it did ...

Gaining inspiration from stars like Johnny Cash and Hank Williams, Billy Don Burns decided to pursue a career in country music. Born and raised in Arkansas, he channeled his love for the state into ...

NEW YORK, Dec 2 (Reuters) - CVS Health (CVS.N), opens new tab will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained improper reimbursements ...

OceanSound Partners has made an investment in Burns Engineering, a Philadelphia-based engineering solutions provider. No financial terms were disclosed. Burns’ existing leadership, management and ...

A 26-week trial reveals that metformin, long viewed as a promising add-on therapy, lowers insulin needs but leaves tissue-level insulin resistance unchanged. Study: Effect of metformin on insulin ...